Rituximab for the treatment of multiple sclerosis: a review.

J Neurol · 2022 · PMC7790722 · PMID 33416999

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In comparison with FTY and NTZ, relapse rates and Gd-enhancing lesions were numerically lower but did not reach statistical significance in all analyses [ 66 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.